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lakophilins are proteins of the armadillo family that
function in embryonic development and in the adult,
and when mutated can cause disease. We have ab-
lated the plakophilin 2 gene in mice. The resulting mutant
mice exhibit lethal alterations in heart morphogenesis and
stability at mid-gestation (E10.5–E11), characterized by
reduced trabeculation, disarrayed cytoskeleton, ruptures
of cardiac walls, and blood leakage into the pericardiac
P
 
cavity. In the absence of plakophilin 2, the cytoskeletal
linker protein desmoplakin dissociates from the plaques of
the adhering junctions that connect the cardiomyocytes
and forms granular aggregates in the cytoplasm. By con-
trast, embryonic epithelia show normal junctions. Thus,
we conclude that plakophilin 2 is important for the assem-
bly of junctional proteins and represents an essential mor-
phogenic factor and architectural component of the heart.
 
Introduction
 
Proteins of the armadillo family are characterized by repeats of
the arm motif, and include molecules such as 
 

 
-catenin, plako-
globin, p120
 
ctn
 
, and the plakophilins (Cowin et al., 1986; Na-
gafuchi and Takeichi, 1989; Ozawa et al., 1989; Peifer and
Wieschaus, 1990; McCrea et al., 1991; Hülsken et al., 1994;
Hatzfeld, 1999). Arm repeat proteins bind to the cytoplasmic
part of glycoproteins of the cadherin family of cell adhesion
molecules, thus forming plaques to which bundles of cytoskel-
etal filaments are tethered (for reviews see Takeichi, 1995;
Smith and Fuchs, 1998; Green and Gaudry, 2000). 
 

 
-Catenin
also plays a crucial role in the canonical Wnt pathway, which
transduces developmental and oncogenic signals from the cell
surface to the nucleus (Behrens et al., 1996; Eastman and
Grosschedl, 1999; Hecht et al., 1999; Bienz and Clevers,
2000). Mutations of plakoglobin in humans (Naxos disease)
and in mice have been reported to result in heart, skin, and hair
follicle dysfunctions, a complex phenotype that might involve
both adhesion and signaling disorders (Bierkamp et al., 1996;
Ruiz et al., 1996; McKoy et al., 2000). A remarkably similar
triad of cardiomyopathy, woolly hair, and keratoderma has
been noted in patients suffering from mutations in the gene en-
coding desmoplakin, another junctional plaque protein (Nor-
gett et al., 2000; Rampazzo et al., 2002; Alcalai et al., 2003).
Plakophilin 1 mutations in humans result in skin fragility-ecto-
dermal dysplasia syndrome, consistent with the restriction of
plakophilin 1 expression to certain stratified epithelia and its
function in keratinocyte adhesion (McGrath et al., 1997; Whit-
tock et al., 2000; Hamada et al., 2002; Sprecher et al., 2004).
Two types of “classical” cell–cell junctions are found in
vertebrates, adherens junctions and desmosomes, which have
one plaque protein in common, plakoglobin (Cowin et al.,
1986). In adherens junctions that comprise morphologically di-
verse forms such as 
 
puncta adhaerentia
 
, 
 
fasciae adhaerentes
 
,
and 
 
zonulae adhaerentes
 
, 
 

 
-catenin links cadherins to 
 

 
-catenin,
thus mediating interaction with the actin cytoskeleton (Boller et
al., 1985; Nagafuchi and Takeichi, 1989; Ozawa et al., 1989;
Hülsken et al., 1994; Aberle et al., 1996). Typical desmosomes
(
 
maculae adhaerentes
 
), which are characterized by the plaque
protein desmoplakin (Franke et al., 1982), are found in epithelial
cells, cardiomyocytes, meningothelial cells, and dendritic reticu-
lum cells of lymph node follicles, where they anchor bundles of
intermediate-sized filaments (IFs) of the cytokeratin, the desmin,
or the vimentin type, respectively (Kartenbeck et al., 1983, 1984;
Franke and Moll, 1987; Kuruc and Franke, 1988; van der Loop
et al., 1995). In addition, desmoplakin has also been identified in
the 
 
complexus adhaerens
 
, an adhering junction characteristic of
some endothelia, where it is essential for vascular development,
as demonstrated by gene ablation in mice (Schmelz and Franke,
1993; Schmelz et al., 1994; Valiron et al., 1996; Kowalczyk et
al., 1998; Gallicano et al., 2001; Zhou et al., 2004).
 
Correspondence to Walter Birchmeier: wbirch@mdc-berlin.de
J. Huelsken’s present address is ISREC, CH-1066 Lausanne, Switzerland.
M. Behrend’s present address is Franz Volhard Clinic, D-13125 Berlin, Germany.
Abbreviations used in this paper: ES, embryonic stem; IF, intermediate-sized fil-
ament; wt, wild-type.
 o
n
 April 29, 2008 
w
w
w
.jcb.org
D
ow
nloaded from
 
 JCB • VOLUME 167 • NUMBER 1 • 2004150
 
The plakophilin subfamily of arm repeat proteins com-
prises three members, plakophilins 1–3 (Kapprell et al., 1988;
Hatzfeld et al., 1994, 2000; Heid et al., 1994; Schmidt et al.,
1994, 1997, 1999; Mertens et al., 1996, 1999; Bonné et al.,
1999). The arm protein p0071, occasionally also called plako-
philin 4, is more closely related to another armadillo subfam-
ily comprising proteins p120
 
ctn
 
, ARVCF, and neurojungin
(Schmidt et al., 1999). Plakophilins 1–3 are juxtamembranous
constituents of plaques of desmosomes and certain related
junctions where they are tightly associated with other arm
proteins, cadherins and desmoplakin, and are involved in the
anchorage of IFs (Hatzfeld and Nachtsheim, 1996; Mertens et
al., 1996, 1999; Schmidt et al., 1997, 1999; Bonné et al.,
1999; Kowalczyk et al., 1999; North et al., 1999; Hatzfeld et
Figure 1. Strategy used to disrupt the plakophilin 2 gene. (a) Schematic representation of the plakophilin 2 targeting vector and the wt and mutant
(pkp2) plakophilin 2 locus. Exon sequences are represented by gray boxes; the neo cassette has been fused in opposite transcriptional orientation to
codon 43 of the first exon. Probes used for Southern hybridization are indicated by black horizontal boxes (ext, neo). The sizes of restriction fragments by
XbaI and HindIII digests are indicated. (b) Southern blot analysis of the plakophilin 2 locus from wt (/) and plakophilin 2 heterozygous (/) and ho-
mozygous (/) E10.75 embryos, as examined by external (ext) and neo probes. (c) PCR analysis of the plakophilin 2 locus of wt (/), heterozygous
(/), and homozygous (/) mutant embryos. (d) Western blot analyses for plakophilin 2 synthesis in wt, heterozygous, and homozygous mutant em-
bryos of E10.75. The loading control was performed with an Erk antibody. (e and f) Immunofluorescence microscopy for plakophilin 2 of wt hearts at (e)
E10.75 and (f) E13.75, using antibodies against the COOH terminus of plakophilin 2. Counterstaining of nuclei was with DAPI. For clarity, a dotted line
marks the tissue border between cardiomyocytes and epicard. at, atrium; v, ventricle. Bars, 200 m.
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al., 2000; Bornslaeger et al., 2001; Chen et al., 2002; Koeser
et al., 2003). Plakophilins are also detected in the nucleus; for
example, plakophilin 2 has been found in association with nu-
cleoplasmic RNA polymerase III complexes (Mertens et al.,
1996, 2001; Schmidt et al., 1997, 1999; Bonné et al., 1999).
Although the function of 
 

 
-catenin in the nucleus is well
known (Behrens et al., 1996; Eastman and Grosschedl, 1999;
Hecht et al., 1999; Bienz and Clevers, 2000), similar roles for
plakophilins have not yet been established. Plakophilin 2 oc-
curs in all proliferative epithelial tissues and tumors as well as
in the cardiomyocytes and Purkinje fiber cells of the heart
(Mertens et al., 1996, 1999).
Striking similarities exist between the phenotypes gener-
ated by human and mouse mutations of desmosomal proteins
(Ruiz et al., 1996; Bierkamp et al., 1996; Gallicano et al., 1998,
2001; Armstrong et al., 1999; McKoy et al., 2000; Norgett et
al., 2000; Vasioukhin et al., 2001; Rampazzo et al., 2002; Al-
calai et al., 2003). No mutations for plakophilin 2, which is the
only plakophilin gene expressed in the heart, had been re-
ported. Here, we describe the phenotype of plakophilin 2–defi-
cient mouse embryos, showing distortions of heart morphogen-
esis and stability, followed by cardiac rupture, blood leakage,
and embryonic death. The analysis of the molecular organiza-
tion of the affected tissue has allowed us to propose a molecu-
lar mechanism for these alterations as well as a general role of
plakophilin 2 in junctional plaque organization.
 
Results
 
Generation of plakophilin 2 mutant mice
 
We generated a null mutation of the plakophilin 2 gene by ho-
mologous recombination in embryonic stem (ES) cells. In the
targeting vector, a neo cassette inserted in opposite transcrip-
tional orientation replaced a 7.8-kb genomic fragment from the
NotI site in exon 1 to the BamHI site in intron 1 (Fig. 1 a). Ho-
Figure 2. Phenotypes of wt and plakophilin 2–deficient (pkp2/) mutant em-
bryos at E10.75. (a and b) External appearance of embryos. In the mutant em-
bryo, blood has accumulated in the pericardial and peritoneal cavities, which
are connected at this embryonal stage (Kaufman and Bard, 1999). (c–f) The vas-
culature of the yolk sac contains red blood cells in the wt, but not in the pkp2/
embryos, as shown by whole-mount photography (c and d) and microscopy of he-
matoxylin- and eosin-stained sections of endothelia (e and f). (g and h) The vascu-
lature of wt and pkp2/ mutant yolk sacs is intact, as shown by anti-PECAM
immunostaining of endothelial cells. (i and j) Light microscopy of toluidine blue–
stained transverse sections of embryonic hearts: note the reduced thickness of the
atrial walls and the reduced trabeculation of the ventricle, as well as blood accu-
mulation in the pericardial cavity of pkp2/ mutant hearts (arrow); ra and la,
right and left atria; bc and cv, bulbus cordis (future right ventricle) and common
ventricle (future left ventricle). (k and l) Higher magnifications of atrial walls in wt and plakophilin 2 / mutant hearts. In general, the atrial walls appear
thinner in the mutant (l). The position of a possible small leakage site is indicated (arrowhead) in the mutant hearts (l); ed, endocardial cells; ep, epicardial
cells; cm, cardiomyocytes; rb, red blood cells. Bars: 1,000 m (a, b, c, d, g, and h), 100 m (e and f), 300 m (i and j), 50 m (k and l).
 
Table I. 
 
Viability of embryos resulting from heterozygous intercrosses
Stage
 

 
/
 
 
 
/
 
 
 
/
 

 
E9.75 32% (15) 40% (19) 28% (13)
E10.75 26% (25) 48% (46) 26% (25)
E11.5 29% (21) 49% (35) 22% (16)
- - 7%
 
a
 
 (5)
E13.75 30% (4) 69% (9) 0%
 
a
 
The number of dead homozygous mutant embryos; the number of tested em-
bryos is in parentheses.
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mologous recombination events were identified by Southern
blot analyses (Fig. 1 b): an external probe (ext) yielded a novel
Xba fragment of 10 kb in the mutant, 
 

 
pkp2 (the wild-type
[wt] fragment is 16 kb), and the neo probe produced a 4.5-kb
HindIII fragment. We generated a null mutation in the plako-
philin 2 gene after homologous recombination because inser-
tion of neo prevents splicing between exon 1 and 2 and leads
to an early stop of plakophilin 2 translation after 43 aa. Using
two lines of mutant ES cells, we produced plakophilin 2 mu-
tant chimeric and heterozygous mice that were healthy and fer-
tile. However, matings between heterozygous mice produced
no live plakophilin 2–deficient offspring, implying that the
mutant embryos died during embryogenesis. To determine the
time of death, embryos from different developmental stages
were genotyped by PCR (Fig. 1 c) and inspected visually. Up
to day 10.75 of embryogenesis (E10.75), the expected Mende-
lian ratio of homozygous mutant embryos was observed (Ta-
ble I); however the mutant embryos showed blood accumula-
tion in the pericardial and peritoneal cavities. At E11.5, the
number of viable plakophilin 2 
 

 
/
 

 
 embryos declined, as
judged by PCR genotyping and lack of heart beating. Western
blot analyses using an antibody against the COOH terminus of
plakophilin 2 indicated absence of full-length or truncated pro-
tein in E10.75 plakophilin 2 
 

 
/
 

 
 embryos (Fig. 1 d). In wt
embryos at E10.75, plakophilin 2 was prominent in cardio-
myocytes of the atrium and the ventricle of the heart (Fig. 1 e),
and expression was lost in the null mutation embryos (see also
below, Fig. 4 Bd
 

 
, and Fig. 8). At E13.75, plakophilin 2 was
intensely synthesized in the wt cardiomyocytes, but less in the
surrounding epicard (Fig. 1 f).
 
Defects in heart morphogenesis of 
plakophilin 2 
 

 
/
 

 
 embryos
 
To determine the cause of lethality in plakophilin 2–deficient
mice, we examined embryos at E9.5 and later stages of devel-
opment. Homozygous embryos at E10.75 were pale in the
head and the dorsal trunk region, i.e., blood was not distrib-
uted homogenously but had accumulated in the pericardial
cavity and also in the peritoneal cavity (Fig. 2, a and b). Simi-
larly, blood was not found in the blood vessels of the yolk sacs
of homozygous plakophilin 2 
 

 
/
 

 
 embryos (Fig. 2, c and d;
see section through blood vessels in Fig. 2, e and f).The vascu-
lature appeared to be largely intact, as determined by PECAM
staining, although some minor alterations in the overall pattern
of the blood vessel network could be recognized (Fig. 2, g and
h). Transverse sections through the forming heart of the plako-
philin 2 mutants at E10.75 showed reduced trabeculation in
the heart ventricles (Fig. 2, i and j) and thinner walls of the
atria, as in some places two cell layers instead of three to four
in the wt embryos were observed (Fig. 2, k and l; see also Fig.
3 and Sedmera et al., 2000). No alterations in cell prolifera-
tion and apoptosis were seen in mutant hearts, as determined
by anti-phosphohistone 3 and TUNEL staining (unpublished
data). Overt rupture of heart walls, as previously found in
plakoglobin-deficient mutant embryos (Ruiz et al., 1996),
could not be detected, indicating that blood leakage occurred
through small perforations of the beating heart (the position of
a possible small leakage site is denoted by an arrowhead in
Fig. 2 l). Homozygous embryos of earlier stages (E9.5–E10)
did not show blood leakage into the pericard, whereas em-
bryos of E11.5–E12 displayed, in addition to blood leakage,
swollen pericardiac and peritoneal cavities, before they be-
came necrotic (unpublished data).
 
Changes of cytoskeletal architecture and 
composition of adhering junctions in 
hearts of plakophilin 2 
 

 
/
 

 
 embryos
 
Desmoplakin represents a major and functionally essential
component of adhering junctions in the intercalated disks that
connect cardiomyocytes (Franke et al., 1982; Gallicano et al.,
2001). In the wt embryonic heart at E10.75, desmoplakin was
distributed throughout the trabeculae in a complex punctate pat-
tern at cell–cell borders of both proliferating and differentiating
cardiomyocytes (Fig. 3; see also Moorman and Lamers, 1999).
Confocal laser-scanning, double-label immunofluores-
cence microscopy was used to examine molecular localiza-
tions in the intercalated disks of wt and mutant embryonic
hearts (Fig. 4, A and B). In wt hearts at E10.75, desmoplakin
(green fluorescence) showed far-reaching colocalization with the
junctional proteins plakoglobin, N-cadherin, 
 

 
-catenin, plako-
philin 2, desmoglein Dsg2 (red fluorescence), 
 

 
-catenin, and
p120
 
ctn
 
, as demonstrated by the merged yellow fluorescence
(Fig. 4 A, right column; unpublished data). However, in the
plakophilin 2–deficient mutants desmoplakin did not colocal-
ize with any of these junction proteins (Fig. 4 B, right column),
but was rather dispersed over the cytoplasm, mostly away from
the intercalated disks. Our immunolocalization analyses also
confirmed that plakophilin 2 was absent in these mutants (Fig.
4 Bd
 

 
). Surprisingly, the desmosomal cadherin desmoglein 2
could not be localized at significant levels in the plakophilin
2–devoid hearts (Fig. 4 Be
 

 
).
Figure 3. Survey immunofluorescence micrograph of a sagittal cryostat
section through the ventricle of a whole E10.75 wt embryonic heart, re-
acted with mAbs to desmoplakin. Note the predominantly “spongy” tra-
becular organization of the myocardiac tissue, visualized here by the
punctate pattern of desmoplakin-containing adhering junctions in the tra-
beculae surrounding and traversing the forming ventricle (for histological
details see Moorman and Lamers, 1999). Bar, 20 m.
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Electron microscopy showed that throughout mid-gesta-
tion, the cardiomyocytes of the wt embryos were connected
by well-organized intercalated disks that were rich in both
types of adhering junctions, the 
 
fascia adhaerens
 
–like and the
desmosome-like subforms (Fig. 5 a). In the hearts of plako-
philin 2 
 

 
/
 

 
 mutants, these two morphotypes of adhering
junctions were difficult to distinguish (Fig. 5 b). Electron mi-
croscopy and immunogold labeling of wt hearts demonstrated
that desmoplakin was located in the plaques of both the des-
mosome-like and 
 
fascia adhaerens
 
–type junctions (Fig. 5,
c, e, and g), confirming previous observations (Borrmann,
2000), although a somewhat higher intensity of labeling was
generally seen in the more desmosome-like junctions (Fig. 5
e, compare right-hand with left-hand junction). “Fused” type
junctions with continuous desmoplakin or plakophilin 2 label-
ing were also consistently observed in wt hearts (Fig. 5, g
and h). Both morphotypes of adhering junctions were also
strongly positive for the major transmembrane glycoprotein,
N-cadherin (Fig. 5 k).
By contrast, in the hearts of the plakophilin 2–deficient
embryos the location of desmoplakin was drastically altered:
immunogold labeling demonstrated that desmoplakin was
virtually absent from all junctions (Fig. 5, d and f). Instead,
desmoplakin immunolabel was found in sparse distribution
over the cytoplasm and often appeared at dense granular ag-
gregates of diameters of up to 1 
 

 
m, mostly located deep be-
tween the bundles of myofibrils or in association with the tan-
gles of IFs (Fig. 5, i and j), which were positive for desmin
and for vimentin (unpublished data). However, the distribu-
tion of N-cadherin and other plaque components examined
Figure 4. Major architectural and compositional changes of the adhering junctions in the intercalated disks of hearts in plakophilin 2–deficient E10.75
mouse embryos. Laser-scanning, double-label immunofluorescence microscopy of cryostat sections through cardiac tissue, performed with wt and plako-
philin 2–deficient (pkp2/) embryos. Specific combinations of antibodies were used: rabbit antibodies to desmoplakin (DP, marked by green fluores-
cence) and murine mAbs to diverse other cardiac adhering junction components (red fluorescence): (a and a) plakoglobin (PG); (b and b) N-cadherin
(N-Cad); (c and c) -catenin (-Cat); (d and d) plakophilin 2 (PKP2); (e and e) desmoglein 2 (Dsg2). The merged fluorescence images are shown in the
right-hand column. (A) In the wt embryos, the special adhering junctions of the intercalated disks show far-reaching colocalization (yellow) of desmoplakin
with (a) plakoglobin, (b) N-cadherin, (c) -catenin, (d) plakophilin 2, and (e) desmoglein 2. Other known plaque proteins of cardiac adhering junctions
show identical localization, including p120ctn and -catenin (see also Janssens et al., 2001). (B) By contrast, in the pkp2/ embryos none of the plaque
proteins colocalize with desmoplakin (a–e). In the mutants, desmoplakin is dispersed over the cytoplasm, often appearing in granular aggregates (green
dots). (d) Complete absence of plakophilin 2 immunostaining in the mutant embryos is shown. (e) Note that Dsg2 is not detectably enriched in the inter-
calated disks of the mutants. Bars, 50 m.
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(e.g., 
 

 
- and 
 

 
-catenin) was not significantly altered in the
hearts of the wt and the plakophilin 2–deficient embryos (Fig. 5,
k and l; unpublished data). In many places, IF arrays appeared
locally displaced by the aggregates of desmoplakin granules
(Fig. 5, i and j). The extent of changes of cytoskeletal organiza-
tion in the absence of plakophilin 2 is presented at higher mag-
nification in Fig. 6: we frequently observed conspicuous IF ar-
rays, which appeared as extensive swirls of disordered filaments
around the dense desmoplakin aggregates (Fig. 6, arrow). In ad-
dition, some desmoplakin immunolabel was always identified
in association with the extensive IF tangles (Fig. 6).
Remarkably, the ultrastructure of adherens junctions and
desmosomes in epithelial tissues, such as in the forming epider-
mis and in stomach mucosa, was not altered in the plakophilin
2–deficient mutant mice (Fig. 7). Similarly, no significant mor-
phological changes were noted in the aorta as well as in endo-
thelia of blood vessels (unpublished data).
 
Biochemical differences of molecular 
complexes in adhering junctions of 
embryonic hearts
 
It has previously been demonstrated that in tissues as well as
in monolayer cell cultures of epithelial cells and of cardio-
myocytes, junctional proteins such as plakophilins are to a
large extent associated with the cytoskeleton and thus not
readily extractable by nondenaturing detergents such as Tri-
ton X-100 or NP-40 at moderate ionic strength (Mertens et
al., 1996, 2001; Bornslaeger et al., 2001; Koeser et al., 2003).
Similarly, we found that in the forming hearts of wt embryos
large proportions of desmoplakin, plakoglobin, 
 

 
-catenin, and
plakophilin 2 (but also of the transmembrane glycoproteins
N-cadherin and desmoglein 2) were detergent insoluble (Fig.
8, left column). In contrast, in plakophilin 2–deficient embry-
onic hearts, desmoplakin and desmoglein 2, and in part also
plakoglobin were largely Triton X-100 soluble (i.e., less sta-
bly associated with the cytoskeleton), whereas the cytoskele-
tal associations of N-cadherin and 
 

 
-catenin were unchanged
(Fig. 8, compare left and right column). In addition, low
amounts of desmoglein 2 were recovered from mutant embry-
onic hearts (Fig. 8, compare left and right columns). We con-
clude from these biochemical data that the association of
desmoplakin and plakoglobin, but also of desmosomal cad-
herins with their partners in the cardiac junctional plaques, is
strongly reduced in the plakophilin 2–deficient embryonic
hearts, consistent with reduced architectural stability of the
intercalated disks.
Figure 4 (continued from previous page)
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Discussion
Ablation in mice of the gene encoding plakophilin 2, a wide-
spread protein with dual location in intercellular junctions and
in nuclei, results in lethal cardiac damage at mid-gestation. De-
fective cell–cell adhesion at the intercalated disks and leakage
of blood into the pericardial cavity is observed, and electron
microscopic as well as biochemical data demonstrate a mark-
edly reduced association of plaque proteins such as des-
moplakin and plakoglobin with the junctional structures. These
alterations occur at similar time periods (E10.5–E12) and with
similar pathological alterations as those previously shown for
the ablations of another arm protein plaque constituent, plako-
globin (Bierkamp et al., 1996; Ruiz et al., 1996), and in part for
the cell–cell adhesion molecule N-cadherin (Radice et al.,
1997). Ablations of the genes encoding the cytoskeletal linker
protein desmoplakin (Gallicano et al., 1998) and the desmo-
somal cadherin Dsg2 (Eshkind et al., 2002), two other major
components of cardiac adhering junctions, disrupt earlier
stages of embryogenesis, but specific damage in embryonic
hearts has been noted upon partial rescue of desmoplakin (Gal-
licano et al., 2001; Zhou et al., 2004). We conclude from these
results that (1) the developing embryonic heart is particularly
vulnerable to diverse forms of weakening of cardiomyocyte ad-
hesion, and (2) plakophilin 2 is a key organizer of cardiac ar-
chitecture during embryogenesis. The latter conclusion is in
line with several observations on plakophilin 2–binding pro-
teins in other cultured cells (Chen et al., 2002; Koeser et al.,
Figure 5. Dissociation of desmoplakin from
the cardiac adhering junctions (areae compos-
itae) in the absence of plakophilin 2. Electron
(a and b) and immunoelectron (c–l) micros-
copy of ultrathin sections through intercalated
disk junctions that connect cardiomyocytes of
forming hearts in wt and plakophilin 2–defi-
cient (pkp2/) E10.75 embryos. Desmo-
some-like structures (an example is seen in the
top part of a) are not seen in the pkp2/
embryos (b). Although the electron micro-
scopic appearance of plaque-bearing junc-
tions of the fascia adhaerens type is similar in
both the wt and the mutant embryos (bottom
part of a and b), the localization of des-
moplakin (DP), as seen in immunoelectron mi-
crographs (c–g, i, and j), is drastically altered:
in the wt embryos, desmoplakin immunogold
label is enriched in plaques of both morpho-
types of adhering junctions (c and e), usually
with higher label intensity at desmosome-like
structures (e, compare the right hand junction
with the fascia adhaerens–like junction in the
left), including “fused” junctions with a practi-
cally continuous DP positivity (g). The same lo-
calization is seen for plakophilin 2 immuno-
label in the wt hearts (h). By contrast, the
pkp2/ embryos show no desmoplakin en-
richment at junctional plaques. Instead, DP la-
bel is dispersed over the cytoplasm, showing
no significant enrichment at plaques (d and f),
and is markedly enriched in dense granular
aggregates of various sizes occurring through-
out the cytoplasm, where they are interspersed
between myofibrillar bundles (i) or in close as-
sociation with loose arrays of IFs (j, for higher
magnification see the inset). In contrast, other
constituent proteins of these junctions are de-
tected at comparable intensity in both wt and
pkp2/ embryos (k and l present the com-
parison for N-cadherin). Bars: 1 m (b), 0.5
mm (a, c–g, i, and j), 0.2 m (h, k, and l),
and 0.1 mm (j, inset). Asterisk marks a cell
junction devoid of desmoplakin.
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2003). The fact that plakophilin 2 is the only plakophilin
present in cardiac adhering junctions may explain this extraor-
dinary sensitivity in mutant hearts.
The analysis of the molecular changes in the cytoskeletal
architecture of the plakophilin 2 mutant hearts has, however,
revealed striking differences to ablations of plakoglobin and
N-cadherin: while in plakoglobin-deficient embryonic hearts
desmoplakin remains firmly associated with the plaques of the
adhering junctions (Ruiz et al., 1996), this protein is no longer
associated with the junctions in the absence of plakophilin 2.
Rather, in the plakophilin 2–deficient embryonic hearts des-
moplakin is dispersed over the cytoplasm, where it frequently
forms sizable aggregates located between the myofibril and IF
arrays, away from the intercalated disks. We conclude there-
from that it is plakophilin 2, possibly together with plakoglo-
bin, which is essential for fixing desmoplakin to the junctional
plaques of cardiomyocytes. Our work also shows that both pla-
kophilin 2 and desmoplakin are not required for the anchorage
of myofibrils to adhering junctions of cardiomyocytes (see Fig.
5, a and b), as this has also been shown for plakoglobin (Isac et
al., 1999). By contrast, the IF arrays normally interspersed be-
tween the myofibrils and enriched at the intercalated disks
(e.g., Kartenbeck et al., 1983; Milner et al., 1996) are often
displaced in the mutant, but still display associations with
desmoplakin, including formations of swirls around the des-
moplakin aggregates. These associations between IFs and
desmoplakin away from the plasma membrane reflect the inti-
mate binding of these proteins, compatible with results in cul-
tured epithelial cells (Stappenbeck and Green, 1992; Stappen-
beck et al., 1993; Kouklis et al., 1994; Bornslaeger et al., 1996,
2001; Smith and Fuchs, 1998; Kowalczyk et al., 1999; Va-
sioukhin et al., 2001; Chen et al., 2002). Our immunolocaliza-
tion and biochemical data also demonstrate that in the plako-
philin 2–deficient mouse embryos, several proteins of the
armadillo family such as -catenin, p120ctn, and also part of
plakoglobin remain at the adhering junctions of the cardiac in-
tercalated disks, despite the absence of plakophilin 2 and des-
moplakin. This indicates that their binding to other plaque
components, including the cytoplasmic portion of N-cadherin,
is sufficient to secure their junctional integration. Plakophilin 2
binding, as reported from cell transfection and yeast two-
hybrid experiments (Chen et al., 2002), is therefore not needed
for association of -catenin, p120ctn, and part of plakoglobin
with the cardiac junctions. However, the desmosomal cad-
herins (e.g., Dsg2) were largely absent from desmosomal junc-
tions and were detergent extractable from mutant hearts. This
higher detergent solubility of Dsg2 may be due to its exclusion
from the cardiac junctions, similar to the detergent-extractable
forms of nascent desmoglein from cultured cells (e.g., Pasdar
and Nelson, 1989; Pasdar et al., 1991). Thus, our observations
are compatible with reports on cultured cells that plakophilin 2
Figure 6.  IFs around a granular desmoplakin aggregate in a cardio-
myocyte of a plakophilin 2–deficient E10.75 mouse embryo. Immunoelec-
tron micrograph of an ultrathin section, showing a typical dense granular
aggregate (arrow) containing desmoplakin surrounded by extended swirls
of nonordered, loosely arranged IFs. Note the occurrence of desmoplakin
gold label in the aggregate, as well as being distributed in a dispersed
state over the entire IF swirl. Bar, 0.5 m.
Figure 7. Electron micrographs showing near-normal morphology of
adhering junctions in epithelial tissues at E10.75 of wt and plakophilin
2–deficient embryos. (a and b) In the periderm of the developing epider-
mis of both wt (a) and pkp2/ (b) embryos, desmosomes with similar ul-
trastructure are seen, often adjacent to small adherens junctions (e.g., to
the left of the desmosome in b). (c, wt; d and e, pkp2/) Similarly, both
desmosomes and adherens junctions are seen side by side in other form-
ing epithelia such as in the stomach mucosa. The higher magnification pic-
ture (e) reveals normal plaque thickness and density, trilaminar membrane
appearance, and bridge structures in the intermembranous desmoglea
structure. Bars: 0.1 m (a, b, and e) and 0.5 m (c and d).
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is a stabilizing binding partner of desmosomal cadherins (Chen
et al., 2002; Koeser et al., 2003; see also Chitaev et al., 1996).
In contrast to the myocard, several epithelia show nor-
mal-looking desmosomes in the plakophilin 2–deficient mutant
embryos. These epithelia are known to contain plakophilin 3
(Bonné et al., 1998, 1999; Schmidt et al., 1999), which might
structurally and functionally compensate for the absence of
plakophilin 2. Whether plakophilin 1 can also compensate for
plakophilin 2 in certain suprabasal epithelial cells (for in vitro
experiments see Kowalczyk et al., 1999; Hofmann et al., 2000)
remains to be examined. We have not been able to examine the
functional roles of plakophilin 2 in epithelial differentiation
and function, as the plakophilin 2 / embryos die early.
Hereditary human cardiomyopathies are characterized by
impaired myocardial contractility and ventricular dilatation,
and frequently also affect myofibril function. Mutations in
genes coding for components of the contractile apparatus have
been identified in cardiomyopathy (Thierfelder et al., 1994).
Mutation of titin, a large cytoskeletal and signaling protein of
cardiac muscles, can result in dilated cardiomyopathy with
congestive heart failure (Gerull et al., 2002). After our report
that ablation of the plakoglobin gene in mice leads to heart rup-
ture (Ruiz et al., 1996), it has been found that Naxos disease is
caused by deletion of plakoglobin that results in cardiomyopa-
thy and skin defects (McKoy et al., 2000; Protonotarios et al.,
2001; Narin et al., 2003). Mutations of desmoplakin and other
junctional proteins in humans were recently also found to be
associated with complex heart and skin disorders (Armstrong
et al., 1999; Norgett et al., 2000; Alcalai et al., 2003; for re-
views see Chidgey, 2002; Cheng and Koch, 2004). Therefore,
it is tempting to speculate that other alterations of the plakophi-
lin 2 gene than the null mutation reported here, or other types
of interferences with plakophilin 2 function, might impair heart
function and play a role in human heart disease.
Materials and methods
Generation of mutant mice
The mouse plakophilin 2 gene was isolated from a  FIX II 129/SVJ li-
brary (Stratagene). Restriction analysis and PCR amplification were used
to map and subclone fragments that encompass the exon containing the
translation initiation site and downstream exons. The targeting vector was
created using standard molecular biology techniques, and ES cells were
electroporated and selected as described previously (Huelsken et al.,
2000). Recombined loci were analyzed by Southern blotting, and West-
ern blotting was used to demonstrate that the modified plakophilin 2 locus
produced a null allele. Two independent heterozygous ES cell clones of
the mutated allele were used to generate chimeric mice by blastocyst injec-
tion (Huelsken et al., 2000), and mutant animals were bred on a C57Bl6
background. PCR genotyping was performed using oligonucleotides 5-
GATCCTGGGTCACCTGGACA-3 and 5-AGGGTCTGCTGCACCTGCT-
3 for the wt allele, and 5-GATCCTGGGTCACCTGGACA-3 and 5-CTT-
CTGAGGGGATCGGCAATA-3 for the mutant allele.
Histology and immunohistochemistry
Embryos and yolk sacs were fixed in PBS containing 4% formaldehyde
freshly prepared from paraformaldehyde, washed, embedded in paraffin,
and sections were stained with hematoxylin and eosin. Transverse Epon
sections of wt and plakophilin 2–deficient embryos were stained with tolu-
idine blue. For whole-mount immunohistochemistry, embryos were fixed in
methanol/DMSO and incubated with primary anti PECAM-1 antibody
(mAb; BD Biosciences), followed by incubation with secondary POD-con-
jugated donkey anti–rat antibody (Dianova) in 2% dissolved milk powder.
DAB was used for color detection.
Immunofluorescence microscopy
Cryostat sections of wt and homozygous plakophilin 2 mutant mouse em-
bryos at E10.75 were fixed with acetone at 20	C for 10 min, and were
incubated with guinea pig or mouse mAbs to plakophilin 2 (Mertens et al.,
1996, 2001; Borrmann, 2000), antibodies to desmoplakin (mAb “DP
mix” from Progen Biotechnik GmbH, or polyclonal rabbit antibodies from
NaTuTec), murine mAbs, guinea pig or rabbit antibodies to desmoglein
Dsg2 (Progen; Schmelz et al., 1986; Nuber et al., 1996; Schäfer et al.,
1996; Kurzen et al., 1998), -catenin (mAb; Zymed Laboratories), N-cad-
herin (mAb; Transduction Laboratories), or plakoglobin (mAb; Progen).
Murine mAbs and guinea pig antibodies specific for cardiac -actin,
desmin and vimentin (all from Progen), or for plakophilin 2 (Mertens et al.,
1996, 1999) were applied. Fixed sections were exposed to primary anti-
bodies for 30 min, followed by three washes with PBS and incubation
with secondary antibodies coupled to Alexa 568 or Alexa 488 (MoBiTec)
for 30 min. Samples were rinsed with PBS and mounted with Fluoromount
(Biozol). Fluorescence micrographs were taken with Axiophot and LSM
510 microscopes (both from Carl Zeiss MicroImaging, Inc.).
Electron and immunoelectron microscopy
Embryos were dissected and fixed in 8% formaldehyde/0.1% glutaralde-
hyde in HEPES, osmicated, and embedded in Epon (Poly/Bed 812; Poly-
sciences) using standard procedures. For immunoelectron microscopy, 5-m-
thick cryostat sections were mounted on coverslips, fixed for 10 min with
2% formaldehyde in PBS, permeabilized with 0.1% saponin in PBS for
5 min, and incubated for 1 h with the primary antibodies. After three
washes with PBS, specimens were incubated with secondary, Nanogold-
Figure 8. Triton X-100 solubility of junctional proteins in the hearts of wt
and plakophilin 2 mutant (pkp2/) embryos at E10.75. Triton X-100 in-
soluble and soluble proteins were subjected to SDS-PAGE and the relative
amounts of specific proteins were demonstrated by Western blotting using
antibodies to junctional proteins as listed. Note that a large proportion of
desmoplakin and desmoglein 2 and, to a lesser degree, plakoglobin,
were not associated with the Triton X-100 insoluble (i.e., cytoskeleton-
associated) fraction in the plakophilin 2–deficient hearts. Plakophilin 2
was absent in mutant hearts, and -catenin as well as N-cadherin did not
show marked differences between wt and pkp2/ animals.
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conjugated antibodies (BioTrend) for 2–4 h. Further treatment, including
silver enhancement of the gold particles, was as described previously
(Langbein et al., 2002). Samples were dehydrated and flat-embedded in
Epon. Ultrathin sections were examined with an electron microscope
(model EM 910; Carl Zeiss MicroImaging, Inc.).
Detergent extraction, gel electrophoreses, and Western blots
For Triton X-100 extraction, embryonic hearts were snap-frozen in liquid
nitrogen and genotyped. Hearts were pooled, sonicated in lysis buffer (20
mM Hepes, pH 7.4, 150 mM NaCl, 0.5 mM CaCl2, and 1% Triton
X-100), and centrifuged at 20,000 g for 15 min. Protein concentration
was measured, and equal amounts of the Triton X-100 insoluble and soluble
fractions were subjected to SDS-PAGE and transferred to nitrocellulose,
and blots were probed several antibodies (see above) including -tubulin
(Sigma-Aldrich) and pan-Erk (Cell Signaling, New England Biolabs, Inc.).
For Western blotting, embryonic tissues were sonicated in ice-cold PBS
and were boiled in SDS-containing loading buffer for 10 min at 95	C,
and the homogenate was centrifuged. Equal amounts of total protein were
subjected to SDS-PAGE, and blots were probed with the antibodies de-
scribed above.
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